Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
KEY FINDINGS BAR (8 stat cards) STAT 1: $150B - projected global category size by 2030 STAT 2: ~58% - of total category AI citation share captured by six pharma brands STAT 3: 2 - companies (Novo Nordisk and Eli Lilly) own nearly 100% of GLP-1 citations STAT 4: ~13% - AI Overview trigger rate on health queries, highest of any consumer category STAT 5: 60-70% - share of "best diet app" AI answers citing MyFitnessPal first STAT 6: 200M+ - registered MyFitnessPal user base, the informational moat behind its citation lock STAT 7: 60+ - consumer prompts tracked across ChatGPT, Claude, Perplexity, and Google AI Overviews to build the index STAT 8: 25 - brands ranked, with the remaining ~11% citation share split across ranks 16-25 and unranked brands THE TOP 15 BY AI CITATION SHARE Estimated share of citations across 60+ weight-loss-related consumer prompts run through ChatGPT, Claude, Perplexity, and Google AI Overviews, Q1 2026
40 units is 0.4 mg from one vial and 2.0 mg from another a five-fold difference from the same mark on the same syringe
Clinical experience suggests that higher-dose formulations approved for weight management (rather than diabetes-only doses) are generally necessary to achieve meaningful weight loss in the post-bariatric population
Front Neurol 8:588 Bodaghi-Namileh V, Sepand MR, Omidi A, Aghsami M, Seyednejad SA, Kasirzadeh S, Sabzevari O (2018) Acetyl-l-carnitine attenuates arsenic-induced liver injury by abrogation of mitochondrial dysfunction, inflammation, and apoptosis in rats
Proper technique helps ensure the medication works as intended and reduces discomfort
As clinical data builds up, the race to market dominance gets tougher by the day because major pharmaceutical players are getting ready for commercial launches
